Clinical trial
Bioequivalence Study of Sodium Divalproate Tablets 500 mg
NCT03914534 is registered in ClinicalTrials.gov with Tecnoquimicas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence Study of Sodium Divalproate Tablets 500 mg
- Lead sponsor
- Tecnoquimicas
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 17, 2017
- Completion date
- February 12, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy